TKT and acute myeloid leukemia: We next tested isolated native blasts derived from patients with newly diagnosed AML to confirm the proapoptotic effect observed for quizartinib in in vitro leukemia and isogenic mutant-TK models (IC50s for all patients are provided with Table 2; patient characteristics are available as supplementary material in Additional file 2: Table S1).